Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$451K Sell
4,965
-1,418
-22% -$129K 0.17% 53
2026
Q1
$655K Buy
6,383
+31
+0.5% +$3.5K 0.3% 40
2025
Q4
$796K Buy
6,352
+25
+0.4% +$3.19K 0.39% 34
2025
Q3
$847K Sell
6,327
-33
-0.5% -$4.33K 0.43% 32
2025
Q2
$865K Buy
6,360
+25
+0.4% +$3.3K 0.5% 30
2025
Q1
$840K Buy
6,335
+1,709
+37% +$218K 0.57% 26
2024
Q4
$523K Buy
4,626
+22
+0.5% +$2.54K 0.56% 36
2024
Q3
$525K Buy
4,604
+23
+0.5% +$2.52K 0.45% 35
2024
Q2
$476K Buy
+4,581
New +$486K 0.44% 34

Other funds holding ABT

GGM Financials's ABT Position: Q2 2026 in Review

GGM Financials reduced its Abbott (ABT) stake by 22% in Q2 2026, selling an estimated $129K and leaving 4,965 shares worth $451K. The position accounts for 0.17% of the portfolio, ranked #53.

GGM Financials first reported a position in ABT in Q2 2024 and has held it in 9 quarters since. The position peaked at $865K in Q2 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • GGM Financials held 4,965 shares of Abbott worth $451K as of Q2 2026.
  • GGM Financials sold 1,418 Abbott shares in Q2 2026, an estimated $129K.
  • Abbott made up 0.17% of GGM Financials's portfolio in Q2 2026, its #53 holding.
  • GGM Financials first reported a position in Abbott in Q2 2024 and has held it in 9 quarters since.
  • GGM Financials's Abbott position peaked at $865K in Q2 2025.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on GGM Financials's 13F filing for Q2 2026, filed 23 Jul 2026.